TRUST CO OF VERMONT - HALOZYME THERAPEUTICS INC ownership

HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 207 filers reported holding HALOZYME THERAPEUTICS INC in Q2 2019. The put-call ratio across all filers is 0.15 and the average weighting 0.2%.

Quarter-by-quarter ownership
TRUST CO OF VERMONT ownership history of HALOZYME THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$7,640
+5.9%
2000.0%0.00%
Q2 2023$7,214
-5.6%
2000.0%0.00%
-100.0%
Q1 2023$7,638
-32.9%
2000.0%0.00%0.0%
Q4 2022$11,380
+42.2%
2000.0%0.00%0.0%
Q3 2022$8,000
-11.1%
2000.0%0.00%0.0%
Q2 2022$9,000
+12.5%
2000.0%0.00%0.0%
Q4 2021$8,000
-11.1%
2000.0%0.00%0.0%
Q2 2021$9,000
+12.5%
2000.0%0.00%0.0%
Q1 2021$8,000
-11.1%
2000.0%0.00%0.0%
Q4 2020$9,000
+80.0%
2000.0%0.00%
Q3 2020$5,0000.0%2000.0%0.00%
Q2 2020$5,000
+25.0%
2000.0%0.00%
Q1 2020$4,0000.0%2000.0%0.00%
Q4 2019$4,000
+33.3%
2000.0%0.00%
Q3 2019$3,0000.0%2000.0%0.00%
Q2 2019$3,0000.0%2000.0%0.00%
Q1 2019$3,0000.0%2000.0%0.00%
Q4 2018$3,000
-25.0%
2000.0%0.00%
Q3 2018$4,000
+33.3%
2000.0%0.00%
Q2 2018$3,000
-25.0%
2000.0%0.00%
Q1 2018$4,0000.0%2000.0%0.00%
Q4 2017$4,0002000.00%
Other shareholders
HALOZYME THERAPEUTICS INC shareholders Q2 2019
NameSharesValueWeighting ↓
Third Security, LLC 1,129,551$51,293,0007.24%
First Light Asset Management, LLC 2,050,273$93,103,0005.59%
TRAN CAPITAL MANAGEMENT, L.P. 1,350,870$61,343,0005.06%
SNYDER CAPITAL MANAGEMENT L P 3,176,404$144,241,0004.04%
DOHENY ASSET MANAGEMENT /CA 91,930$4,175,0002.69%
Redwood Investments, LLC 538,656$24,460,0001.97%
HighMark Wealth Management LLC 53,457$2,427,0001.78%
Taylor Wealth Management Partners 85,409$3,878,0001.37%
SILVERARC CAPITAL MANAGEMENT, LLC 66,673$3,028,0001.35%
Granite Investment Partners, LLC 919,029$41,733,0001.29%
View complete list of HALOZYME THERAPEUTICS INC shareholders